JPH05320035A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH05320035A JPH05320035A JP3285527A JP28552791A JPH05320035A JP H05320035 A JPH05320035 A JP H05320035A JP 3285527 A JP3285527 A JP 3285527A JP 28552791 A JP28552791 A JP 28552791A JP H05320035 A JPH05320035 A JP H05320035A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- water
- indica
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は美白作用が高く、皮膚を
滑らかにし、若々しい皮膚を保つ化粧品に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic having a high whitening effect, smoothing the skin and keeping youthful skin.
【0002】[0002]
【従来の技術】サラカ インディカ(Saraka indica )
はまめ科の植物でムユウジュと呼ばれ、ヒンズー教の聖
木である。ムユウジュは常緑高木でふつう4〜8mぐら
いになり、まれに20mを越すものもある。樹皮は厚く
灰赤褐色で葉は羽状複葉をなす。分布は中央〜東部ヒマ
ラヤ山麓、ベンガル東部、インド半島西部、インド北部
に分布し一部では栽培されている。この植物は医薬品と
して利用され、葉は腹痛の薬として、樹皮は生理過多の
治療に止血剤として、また煎じて痔の治療にも利用され
ている原料であるがこれを化粧品に利用した前例はな
い。[Prior Art] Saraka indica
It is a plant of the family blister, called Muyuju, and it is a sacred tree of Hinduism. Muyuju is an evergreen tree that is usually about 4-8m long and rarely exceeds 20m. The bark is thick, grayish reddish brown, and leaves are pinnate compound. It is distributed in the central to eastern foothills of the Himalayas, eastern Bengal, western Indian Peninsula, and northern India, and is cultivated in some areas. This plant is used as a medicine, leaves are used as a medicine for abdominal pain, bark is used as a hemostatic agent for the treatment of excessive menstruation, and it is also used as a raw material for the treatment of hemorrhoids after decoction. Absent.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、美白
作用が高く、皮膚を滑らかにし、若々しい皮膚を保ち、
且つ安全性が高く、原料が入手しやすい化粧品原料を提
供することにある。DISCLOSURE OF THE INVENTION The object of the present invention is to have a high whitening effect, to make the skin smooth, to keep youthful skin,
Moreover, it is to provide cosmetic raw materials that are highly safe and easily available.
【0004】[0004]
【課題を解決するための手段】本発明者らは、前記の課
題を解決するため、古くより生薬として内用され、安全
性が確認されている植物抽出物について、鋭意研究を行
った結果、サラカ インディカの抽出物が皮膚に適用し
て、美白作用等優れた効果があることを見い出し、本発
明を完成した。Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors have conducted earnest research on plant extracts that have been used internally as crude drugs for a long time and have been confirmed to be safe. The present invention was completed by applying the extract of Salaca indica to the skin and finding that it has excellent effects such as a whitening effect.
【0005】すなわち本発明は、サラカ インディカ
(Saraka indica )の溶媒抽出物を含む化粧品である。
サラカ インディカ(Saraka indica )は古くより利用
され、水製或いはエタノールエキスが用いられ、その安
全性は充分に確認されている。That is, the present invention is a cosmetic product containing a solvent extract of Saraka indica.
Saraka indica has been used for a long time, and water or ethanol extract has been used, and its safety has been sufficiently confirmed.
【0006】このサラカ インディカを抽出する溶媒は
エタノール、エタノール等の低級アルコール、グリセリ
ン、プロピレングリコール、1,3ブチレングリコール
等の多価アルコール、アセトン等の親水性有機溶媒と
水、或いはこれらの2種以上の混合溶媒を用いて抽出す
る。しかし化粧品原料の抽出としてはエタノールか水或
いはこれの混合液が最適である。抽出時間はサラカ イ
ンディカの刻み方、温度、撹拌条件によって選択する。The solvent for extracting this salaca indica is ethanol, a lower alcohol such as ethanol, a polyhydric alcohol such as glycerin, propylene glycol, 1,3 butylene glycol, a hydrophilic organic solvent such as acetone and water, or two kinds of these. Extract using the above mixed solvent. However, ethanol, water, or a mixture thereof is most suitable for extracting cosmetic raw materials. The extraction time is selected according to the cutting method, temperature and stirring conditions of Saraca Indica.
【0007】この物質を他の化粧品原料例えばスワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤を添加して、さまざ
まな剤形の化粧品を調製することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。この抽出物の配合量は配合する剤
形、製品の目的によって、或いは共存させる薬剤の有
無、サラカ インディカの産地や種類等によってその効
果の発現は異なるのであるが、乾燥物換算にして、0.
00001〜5重量%、好ましくは0.0001〜2重
量%が適当である。To this substance, other cosmetic raw materials, for example, liquid oil such as suwaran and jojoba oil, solid oil such as beeswax and cetyl alcohol, various activators, moisturizers such as glycerin and 1,3 butylene glycol and various chemicals are added. Thus, cosmetics of various dosage forms can be prepared. For example, a lotion, a cream, a milky lotion, a pack or the like may be used depending on the purpose. The amount of this extract compounded depends on the dosage form to be compounded, the purpose of the product, the presence or absence of a coexisting drug, the place of production and the type of Salaca indica, and the effect is different.
Amount of 00001 to 5% by weight, preferably 0.0001 to 2% by weight is suitable.
【0008】[0008]
【実施例】以下に実施例により、本発明を更に具体的に
説明するが、本発明は、この実施例によって何ら限定さ
れるものではない。先づ、実施例で使用した溶媒抽出物
の製造方法について述べる。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. First, a method for producing the solvent extract used in the examples will be described.
【0009】(製造例1)サラカ インディカの樹皮5
0gにメタノール500mlを加えて3時間、還流冷却管
をつけて加熱した。冷却後、濾過した後、減圧濃縮後、
凍結乾燥した。Production Example 1 Saraka Indica Bark 5
500 ml of methanol was added to 0 g, and the mixture was heated for 3 hours with a reflux condenser attached. After cooling, filtering, and concentration under reduced pressure,
Lyophilized.
【0010】(製造例2)サラカ インディカの樹皮5
0gに50%メタノール500mlを加えて3時間、還流
冷却管をつけて加熱した。冷却後、濾過した後、減圧濃
縮後、凍結乾燥した。Production Example 2 Saraka Indica Bark 5
To 0 g, 500 ml of 50% methanol was added and heated for 3 hours with a reflux condenser attached. After cooling, filtration, concentration under reduced pressure, and lyophilization.
【0011】(製造例3)サラカ インディカの樹皮5
0gに精製水500mlを加えて80℃で3時間加熱し
た。冷却後、濾過した後、凍結乾燥した。(Production Example 3) Baraka 5 of Saraca Indica
To 0 g, 500 ml of purified water was added and heated at 80 ° C. for 3 hours. After cooling, filtration and freeze-drying were performed.
【0012】(実施例1)ローション 製造例1の抽出物 1.0 精製水 94.0 グリセリン 4.9 パラオキシ安息香酸メチル 0.1(Example 1) Lotion Extract of Production Example 1 1.0 Purified water 94.0 Glycerin 4.9 Methyl paraoxybenzoate 0.1
【0013】(実施例2)クリーム A スクワラン 20.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 B 精製水 54.9 ポリオキシエチレン(20E.0.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 パラオキシ安息香酸メチル 0.1 製造例2の抽出物 2.0 AはBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。(Example 2) Cream A Squalane 20.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 B Purified water 54.9 Poly Oxyethylene (20E.0.) Sorbitan monostearate 2.0 Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0 Glycerin 5.0 Methyl paraoxybenzoate 0.1 Extract of Production Example 2 2.0 For A, weigh each B, warm to 70 ° C, gradually add A to B with stirring, and then slowly add 30 with stirring.
Cooled to ° C.
【0014】(実施例3)実施例2の製造例2の抽出物
を製造例3の抽出物に置き換えたもの。Example 3 The extract of Production Example 2 of Example 2 was replaced with the extract of Production Example 3.
【0015】(比較例1)実施例1の製造例1の抽出物
を精製水に置き換えたもの。Comparative Example 1 The extract of Production Example 1 of Example 1 was replaced with purified water.
【0016】(比較例2)実施例2の製造例2の抽出物
を精製水に置き換えたもの。Comparative Example 2 The extract of Production Example 2 of Example 2 was replaced with purified water.
【0017】(チロシナーゼ活性阻害率の測定) (試験方法)マックルバルン(Mcllvaln)緩衝液0.9
ml、1.66mM チロシン(Tyrosine)溶液1.0ml、
前記製造例の抽出乾燥物をエタノールに溶解させ、水を
加えた後、エバポレータでエタノールを除去した後、
0.1重量(乾燥物)/容量%に調整した試料検体の規
定濃度水溶液1.0mlをスクリューバイアルにとり、3
7℃恒温水槽中で5分以上加温した。チロシナーゼ溶液
(Sigma社製、マッシュルーム由来、914ユニッ
ト/ml)0.1mlを加え、37℃恒温水槽中で保温し、
10分後に475nmで吸光度を測定した。対照として、
上記試料液のかわりに純水を加え同様に測定した。 (試験式) A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈) チロシナーゼ活性阻害率(%)={B−(A−P)}/
B×100 測定結果を表1に示す。(Measurement of Tyrosinase Activity Inhibition Rate) (Test Method) Mcllvaln Buffer Solution 0.9
ml, 1.0 ml of 1.66 mM Tyrosine solution,
The extracted dried product of the above Production Example was dissolved in ethanol, water was added, and ethanol was removed by an evaporator,
Take 1.0 ml of a specified concentration aqueous solution of the sample specimen adjusted to 0.1% by weight (dry matter) / volume% in a screw vial and
It heated for 5 minutes or more in a 7 degreeC thermostat water tank. Add 0.1 ml of tyrosinase solution (manufactured by Sigma, derived from mushroom, 914 units / ml) and keep warm in a 37 ° C constant temperature water bath,
After 10 minutes the absorbance was measured at 475 nm. As a control
Pure water was added instead of the above sample solution, and the same measurement was performed. (Test formula) A: Absorbance of sample specimen B: Absorbance of control P: Absorbance due to coloring of sample specimen (3-fold dilution) Tyrosinase activity inhibition rate (%) = {B- (AP)} /
B × 100 The measurement results are shown in Table 1.
【0018】[0018]
【表1】 [Table 1]
【0019】大気中には21%の酸素があり、これがな
いと生物(嫌気性のものを除く)は存在しえない。しか
し、酸素は紫外線や酵素等の影響を受けて活性酸素にな
る。活性酸素は脂肪酸を酸化し過酸化物を生成させる。
生体の生体膜のリン脂質も酸化させ、障害を与える。且
つ、生成した過酸化物と活性酸素はDNAに損傷を与
え、老化を促進すると言われている。また、チロシンか
らメラニンを作る機構にも影響を与え皮膚の黒化にも関
与している。この活性酸素を抑制することは皮膚にとっ
て重要な、言い換えれば化粧料に求められる重要な要素
の一つである。活性酸素を抑制する効果を測定する方法
は各種あるが、今回以下の方法を利用した。 pH7.8 50mMリン酸カリウム緩衝液(1.3mM DETAPAC含有)133ml 40unit/mlカタラーゼの上記のリン酸カリウム緩衝液 5ml 2mMニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mMキサンチンの上記のリン酸カリウム緩衝液 17ml 160ml 上の試薬の混合物を2.4ml、検体を0.3ml加えて、
キサンチンオキシナーゼ(予め検体を水とし、実験する
とき、吸光度が1分当たり0.02前後上昇するように
上記のリン酸カリウム緩衝液で調整しておく)液を0.
3ml加えて直ちに吸光度(560nm)を測定する。(測
定は2分位し、直線性を確認する) A:検体を水としたときの1分当りの吸光度の変化 B:検体の1分当りの吸光度の変化 計算式 阻害率=(A−B)/A×100 50%活性酸素生成阻害となる濃度で表して、結果を表
2に示す。There is 21% oxygen in the atmosphere, without which no organisms (except anaerobic) can exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids and produces peroxides.
It also oxidizes and damages the phospholipids of biological membranes in the body. Moreover, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. It also affects the mechanism of melanin production from tyrosine and is involved in skin darkening. Suppressing this active oxygen is one of the important factors required for the skin, in other words, for cosmetics. There are various methods for measuring the effect of suppressing active oxygen, but the following method was used this time. pH 7.8 50 mM potassium phosphate buffer (containing 1.3 mM DETAPAC) 133 ml 40 unit / ml Catalase above potassium phosphate buffer 5 ml 2 mM Nitroblue tetrazolium above potassium phosphate buffer 5 ml 1.8 mM xanthine above Potassium phosphate buffer 17 ml 160 ml Add 2.4 ml of the above mixture of reagents and 0.3 ml of sample,
A solution of xanthine oxinase (prepared with water as a sample in advance and adjusted with the above-mentioned potassium phosphate buffer so that the absorbance increases about 0.02 per minute during the experiment) was used.
Immediately after adding 3 ml, the absorbance (560 nm) is measured. (Measurement is performed for 2 minutes and linearity is confirmed) A: Change in absorbance per minute when the sample is water B: Change in absorbance per minute of sample Calculation formula Inhibition rate = (AB ) / A × 100 The results are shown in Table 2 in terms of the concentration at which 50% active oxygen production is inhibited.
【0020】[0020]
【表2】 [Table 2]
【0021】(使用テスト)女性5名づつの顔面を左右
に分け、一方を実施例、もう一方を比較例として、毎
日、1回以上使用してもらって、3月後、アンケートし
た。なお、10名を2班に分け、下記表3の試料を使っ
て実験した。(Usage Test) Faces of five women were divided into right and left, one of which was used as an example and the other of which was used as a comparative example once or more daily, and a questionnaire was conducted after 3 months. In addition, 10 people were divided into 2 groups and experimented using the samples in Table 3 below.
【0022】[0022]
【表3】 [Table 3]
【0023】判定基準は以下のようでアンケートの結果
をまとめたのが以下の表4である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3The judgment criteria are as follows, and the results of the questionnaire are summarized in Table 4 below. Example is very good 3 Example is considerably good 2 Example is slightly good 1 No difference 0 Comparative example is good −1 Comparative example is good −2 Comparative example Is very good -3
【0024】[0024]
【表4】 [Table 4]
【0025】[0025]
【発明の効果】サラカ インディカの抽出物は美白、肌
荒防止、小皺防止に役に立ち、化粧料の原料として最適
なものである。EFFECTS OF THE INVENTION The extract of Salaca indica is useful for whitening, preventing rough skin and preventing wrinkles, and is the most suitable raw material for cosmetics.
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成3年12月10日[Submission date] December 10, 1991
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0006[Correction target item name] 0006
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0006】このサラカ インディカを抽出する溶媒は
メタノール、エタノール等の低級アルコール、グリセリ
ン、プロピレングリコール、1,3ブチレングリコール
等の多価アルコール、アセトン等の親水性有機溶媒と
水、或いはこれらの2種以上の混合溶媒を用いて抽出す
る。しかし化粧品原料の抽出としてはエタノールか水或
いはこれの混合液が最適である。抽出時間はサラカ イ
ンディカの刻み方、温度、撹拌条件によって選択する。The solvent for extracting this saraca indica is
Extraction is performed using a lower alcohol such as methanol and ethanol, a polyhydric alcohol such as glycerin, propylene glycol, and 1,3-butylene glycol, a hydrophilic organic solvent such as acetone and water, or a mixed solvent of two or more of these. However, ethanol, water, or a mixture thereof is most suitable for extracting cosmetic raw materials. The extraction time is selected according to the cutting method, temperature and stirring conditions of Saraca Indica.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0018[Correction target item name] 0018
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0018】[0018]
【表1】 [Table 1]
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0020[Correction target item name] 0020
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0020】[0020]
【表2】 [Table 2]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 服部 征雄 富山県富山市五福末広町2556−4 2− 203 (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32 (72)発明者 高松 小織 三重県松坂市垣鼻町1207−3 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masao Hattori 2556-4-22-203 Gofuku Suehiro-cho, Toyama City, Toyama Prefecture (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture (72) Inventor Nakamura Masami 6-32 Ikegami Town, Toba City, Mie Prefecture (72) Inventor Koori Takamatsu 1207-3, Kakihana Town, Matsuzaka City, Mie Prefecture
Claims (1)
の溶媒抽出物を含む化粧品。1. The Saraka indica
Cosmetics containing the solvent extract of.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3285527A JPH07108852B2 (en) | 1991-10-07 | 1991-10-07 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3285527A JPH07108852B2 (en) | 1991-10-07 | 1991-10-07 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05320035A true JPH05320035A (en) | 1993-12-03 |
JPH07108852B2 JPH07108852B2 (en) | 1995-11-22 |
Family
ID=17692690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3285527A Expired - Fee Related JPH07108852B2 (en) | 1991-10-07 | 1991-10-07 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07108852B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
JPH0812586A (en) * | 1994-07-01 | 1996-01-16 | Mikimoto Pharmaceut Co Ltd | Antiplasmin agent |
-
1991
- 1991-10-07 JP JP3285527A patent/JPH07108852B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
JPH0812586A (en) * | 1994-07-01 | 1996-01-16 | Mikimoto Pharmaceut Co Ltd | Antiplasmin agent |
Also Published As
Publication number | Publication date |
---|---|
JPH07108852B2 (en) | 1995-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07277944A (en) | Melanism inhibitor | |
JP3502415B2 (en) | Maillard reaction inhibitor | |
JPH1025238A (en) | Preparation for external use for skin | |
JP3263409B2 (en) | External preparation for skin | |
JP5196416B2 (en) | Cosmetic composition containing Limnocitrus litoritalis extract | |
JP2600036B2 (en) | Cosmetics | |
JP3235922B2 (en) | Cosmetics | |
JP2690421B2 (en) | Cosmetics | |
JPH0597653A (en) | Cosmetic | |
JPH0892053A (en) | External preparation for skin | |
JP3584489B2 (en) | External preparation for skin | |
JP4413387B2 (en) | Collagen production promoter, elastase activity inhibitor, collagenase activity inhibitor and skin cosmetic | |
JPH05320035A (en) | Cosmetic | |
JP3235919B2 (en) | Cosmetics | |
JP3545057B2 (en) | Cosmetics | |
JP3113009B2 (en) | Whitening cosmetics | |
JP2774882B2 (en) | Whitening and anti-aging cosmetics | |
JP2778855B2 (en) | Cosmetics | |
JPH0597649A (en) | Cosmetic | |
JP2000212058A (en) | Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor | |
JP3105664B2 (en) | External preparation for skin | |
JP3792745B2 (en) | Tyrosinase inhibitor | |
JP3547155B2 (en) | Active oxygen suppressant | |
JPH11171722A (en) | Preparation for external use for skin | |
JPH04356416A (en) | Skin cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |